Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Aidapak Services is recalling 2.5 mg Bromocriptine Mesylate tablets that may have been mislabeled as 200 mg Caffeine tablets.
Aidapak Services is recalling Digoxin 125 mcg tablets because they may have been mislabeled as Cholecalciferol/Calcium/Phosphorus tablets.
Aidapak Services, LLC is recalling 250 mg Ascorbic Acid tablets because they may have been mislabeled as other prescription or over-the-counter drugs.
Aidapak Services, LLC is recalling 325 mg aspirin tablets because they may have been mislabeled as other prescription medications.
Aidapak Services, LLC is recalling Diltiazem HCL 120 mg tablets that may have been mislabeled as Nicotine Polacrilex 2 mg lozenges.
Aidapak Services, LLC is recalling multivitamin tablets that may have been mislabeled as sitagliptin or loratadine. The FDA classifies this as a Class II recall.
Aidapak Services is recalling 18,282 Cholecalciferol capsules because they may have been mislabeled as other drugs, including Doxycycline and Lamotrigine.
Novartis Consumer Health is recalling specific lots of NeoCitran powder packets because they may contain foreign substances. The products were distributed in the US, Canada, Mexico, and other countries.
Aidapak Services is recalling Mycophenolic Acid tablets that may be mislabeled as Methazolamide. The error could lead to patients taking the wrong medication.
Aidapak Services is recalling Levothyroxine Sodium 88 mcg tablets because they may have been mislabeled as Guanfacine HCl 1 mg tablets.
Aidapak Services, LLC is recalling Calcitriol 0.25 mcg capsules because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling guanfacine HCl tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling Amantadine HCL capsules because they may have been mislabeled as other prescription drugs.
Novartis Consumer Health is recalling Theraflu Nighttime Severe Cold & Cough powder packets because they may contain foreign substances.
Aidapak Services is recalling Liothyronine Sodium 25 mcg tablets because they may have been mislabeled as Levothyroxine Sodium or Hyoscyamine Sulfate.
Aidapak Services is recalling 1 mg tacrolimus capsules that may have been mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Entecavir tablets because they may be mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Venlafaxine HCL 25 mg tablets because they may have been mislabeled as other prescription drugs.
Novartis is recalling Theraflu and related cold medicine powder packets because they may contain foreign substances. The recall affects products distributed in the US, Canada, Mexico, and other countries.
Aidapak Services, LLC is recalling 493 Acyclovir 200 mg capsules because they may have been mislabeled as other prescription drugs.
Novartis is recalling Theraflu Flu & Sore Throat powder packets because they may contain foreign substances. The recall affects 1.6 million cartons distributed in the US and internationally.
Aidapak Services, LLC is recalling 81 mg Aspirin DR EC tablets because they may have been mislabeled as Sotalol HCl or Folic Acid.
Aidapak Services is recalling Methazolamide tablets that may have been mislabeled as Buprenorphine HCL due to a label mixup.
Aidapak Services is recalling Levothyroxine Sodium 112 mcg tablets because they may have been mislabeled as Raltegravir 400 mg.
Aidapak Services, LLC is recalling Docusate Sodium capsules because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.